These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24605866)

  • 1. The use of pharmacological prophylaxis against venous thromboembolism in hospitalised patients with severe active ulcerative colitis.
    Pleet JL; Vaughn BP; Morris JA; Moss AC; Cheifetz AS
    Aliment Pharmacol Ther; 2014 May; 39(9):940-8. PubMed ID: 24605866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden Barriers to Delivery of Pharmacological Venous Thromboembolism Prophylaxis: The Role of Nursing Beliefs and Practices.
    Elder S; Hobson DB; Rand CS; Streiff MB; Haut ER; Efird LE; Kraus PS; Lehmann CU; Shermock KM
    J Patient Saf; 2016 Jun; 12(2):63-8. PubMed ID: 24681420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of venous thromboembolism prophylaxis with fondaparinux or low molecular weight heparin in a large cohort of consecutive patients undergoing major orthopaedic surgery - findings from the ORTHO-TEP registry.
    Donath L; Lützner J; Werth S; Kuhlisch E; Hartmann A; Günther KP; Weiss N; Beyer-Westendorf J
    Br J Clin Pharmacol; 2012 Dec; 74(6):947-58. PubMed ID: 22515679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylaxis against venous thromboembolism in hospitalized medically ill patients.
    Pendergraft T; Liu X; Edelsberg J; Phatak H; Vera-Llonch M; Liu LZ; Oster G
    Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):75-82. PubMed ID: 23300270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study].
    Gouin-Thibault I; Liard F; Van-Ganse E; Vespa L; Gaudin AF; Nachit-Ouinekh F
    Presse Med; 2011 Sep; 40(9 Pt 1):e365-75. PubMed ID: 21515025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
    Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
    J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines.
    Brown A
    Am J Health Syst Pharm; 2012 Mar; 69(6):469-81. PubMed ID: 22382477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the Quality of Inpatient Ulcerative Colitis Management: Promoting Evidence-Based Practice and Reducing Care Variation With an Inpatient Protocol.
    Lewin SM; McConnell RA; Patel R; Sharpton SR; Velayos F; Mahadevan U
    Inflamm Bowel Dis; 2019 Oct; 25(11):1822-1827. PubMed ID: 30980712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
    Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
    World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Analysis of Outcomes for Adult Trauma Patients With Isolated Severe Blunt Traumatic Brain Injury Following Venous Thromboembolism Prophylaxis.
    Elkbuli A; Watts E; Patel H; Chin B; Wright DD; Inouye M; Nunez D; Rhodes HX
    J Surg Res; 2024 Aug; 300():165-172. PubMed ID: 38815515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States.
    Tinsley A; Naymagon S; Trindade AJ; Sachar DB; Sands BE; Ullman TA
    J Clin Gastroenterol; 2013 Jan; 47(1):e1-6. PubMed ID: 22476043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
    Di Nisio M; Porreca E
    Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of venous thromboembolism in the elderly patient.
    Tincani E; Crowther MA; Turrini F; Prisco D
    Clin Interv Aging; 2007; 2(2):237-46. PubMed ID: 18044139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
    Reeves D; Liu CY
    J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: an analysis from the ADHERE national registry linked to Medicare claims.
    Kociol RD; Hammill BG; Hernandez AF; Klaskala W; Mills RM; Curtis LH; Fonarow GC
    Clin Cardiol; 2011 Nov; 34(11):682-8. PubMed ID: 22057910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke.
    Hackett CT; Ramanathan RS; Malhotra K; Quigley MR; Kelly KM; Tian M; Protetch J; Wong C; Wright DG; Tayal AH
    Thromb Res; 2015 Feb; 135(2):249-54. PubMed ID: 25554497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Low Molecular Weight Heparins for Venous Thromboembolism Prevention in Medical Patients-What Is New in 2019?
    Haas S
    Hamostaseologie; 2019 Feb; 39(1):62-66. PubMed ID: 30620990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.